NBS System 6 for OCD
Obsessive Compulsive Disorder
ApprovedActive
Key Facts
About Nexstim
Nexstim is a commercial-stage medical device company with a unique focus on navigated Transcranial Magnetic Stimulation (nTMS). Its proprietary SmartFocus® technology platform integrates patient-specific MRI data with a multi-sphere head model to visualize and navigate the induced electric field (E-field) in the brain in real-time, enabling unprecedented targeting accuracy. The company's NBS systems are used for pre-surgical mapping in neurosurgery and for therapeutic treatment of conditions like depression and obsessive-compulsive disorder (OCD). As a publicly traded company, Nexstim is expanding its commercial footprint and regulatory clearances for its latest NBS System 6.
View full company profileTherapeutic Areas
Other Obsessive Compulsive Disorder Drugs
| Drug | Company | Phase |
|---|---|---|
| OCD Clinical Trials | Boston Clinical Trials | Not Specified (Typically Phase 2-3) |
| Obsessive Compulsive Disorder Studies | Noesis Pharma Clinical Trials | Phase 2-4 |
| TMS for OCD | Magstim | Commercial/Clinical Development |